Renal Cancer - Results from #5240

Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity April 10, 2017

Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma April 10, 2017

Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions April 10, 2017

Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - important implications for Epithelial to Mesenchymal Transition (EMT) in Renal Cell Carcinoma. April 7, 2017

Effect of Systemic Inflammation on Survival in Patients With Metastatic Renal Cell Carcinoma Receiving Second-line Molecular-targeted Therapy April 7, 2017

New technique for nephron-sparing surgery in polar tumours. A modification of the Kim technique. April 7, 2017

End-stage renal disease secondary to renal malignancy: Epidemiologic trends and survival outcomes April 6, 2017

Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma April 6, 2017

Vascular Endothelial Growth Inhibitor, a Cytokine of the Tumor Necrosis Factor Family, is Associated With Epithelial-Mesenchymal Transition in Renal Cell Carcinoma. April 6, 2017

Renal Medullary Carcinoma; A Rare Entity April 5, 2017

miR-10b is a prognostic marker in clear cell renal cell carcinoma April 5, 2017

Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma April 4, 2017

Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment April 4, 2017

Whole-genome analysis of papillary kidney cancer finds significant noncoding alterations April 4, 2017

[Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 24 cases] April 4, 2017

PD-L2: A prognostic marker in chromophobe renal cell carcinoma? April 4, 2017

LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma April 4, 2017

ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma April 4, 2017

Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of (99m)Tc-sestamibi SPECT/CT April 3, 2017

Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma April 3, 2017

Page 263 of 456